CORRELATION BETWEEN PARTICIPATION IN HIV PREVENTION PROGRAMS AND HARMFUL PRACTICES AMONG PEOPLE WHO INJECT DRUGS IN SEVERAL REGION OF RUSSIAN FEDERATION

A N Barinova; S L Plavinski; N H Vinogradova

doi:10.17816/RFD2014418-23

Russian Family Doctor ›› 2014, Vol. 18 ›› Issue (4) : 18 -23. DOI: 10.17816/RFD2014418-23

Articles

research-article

CORRELATION BETWEEN PARTICIPATION IN HIV PREVENTION PROGRAMS AND HARMFUL PRACTICES AMONG PEOPLE WHO INJECT DRUGS IN SEVERAL REGION OF RUSSIAN FEDERATION

Author information +

History +

PDF

Abstract

Injecting drug users (IDU) have high risk of acquisition of HIV and other blood-borne viruses, because they frequently share needles, syringes and other injecting paraphernalia. The article analyzes the prevalence of harmful practices among IDU and how the behavior changes among participants of harm reduction programs. It is shown that proportion of those engaging in harmful practices are decreasing, but remains relatively high, demonstrating epidemiological significance of those practices for development of HIV epidemics.

Keywords

drugs / HIV / prevention

Cite this article

Download citation ▾

A N Barinova, S L Plavinski, N H Vinogradova. CORRELATION BETWEEN PARTICIPATION IN HIV PREVENTION PROGRAMS AND HARMFUL PRACTICES AMONG PEOPLE WHO INJECT DRUGS IN SEVERAL REGION OF RUSSIAN FEDERATION. Russian Family Doctor, 2014, 18(4): 18-23 DOI:10.17816/RFD2014418-23

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Кошкина Е. А., Киржанова В. В., Сидорюк О. В. и др. Основные показатели деятельности наркологической службы в Российской Федерации в 2011-2012 годах. - М.: ФГБУ «Национальный научный центр наркологии», 2013. - С. 166.

[2]	Gibson D. R., Flynn N. M., Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users // AIDS. - 2001. - Vol. 15. - № 11. - P. 1329-1341.

[3]	Wodak A., Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence // Subst Use Misuse. - 2006. - Vol. 41. - № 6-7. - P. 777-813.

[4]	Плавинский С. Л., Баринова А. Н., Бобрик А. В. и др. Сексуальное поведение ВИЧ-инфицированных лиц группы риска. Необходимость дальнейшего усиления профилактической работы // ВИЧ-инфекция и иммуно-супрессии. - 2009. - Т. 1. - № 1. - С. 102-108.

[5]	Плавинский С. Л., Бобрик А. В., Баринова А. Н. и др. Эффективность программ снижения вреда для предотвращения распространения ВИЧ-инфекции в Российской Федерации // Российский семейный врач. - 2009. - Т. 13. - № 2. - С. 20-24.

[6]	Robertson J. R., Bucknall A. B., Welsby P. D. et al. Epidemic of AIDS relatedvirus (HTLV-III/LAV) infection among intravenous drug abusers // Br. Med. J. (Clin. Res. Ed). - 1986. - Vol. 292. - № 6519. - P. 527-529.

[7]

Burns S. M., Brettle R. P., Gore S. M. et al. The epidemiology of HIV infection in Edinburgh related to the injecting of drugs: an historical perspective and new insight regarding the past incidence of HIV infection derived from retrospective HIV antibody testing of stored samples of serum // J. Infect. - 1996. - Jan. - Vol. 32. - № 1. - P. 53-62.

[8]	Tilson H., Aramrattana A., Bozzette S. et al. Preventing HIV infection among injecting drug users in high-risk countries: an assessment of the evidence. - Washington: Institute of Medicine, 2006. - 298 p.

[9]	Van Beek I., Dwyer R., Dore G. J. et al. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study // BMJ. - 1998. - Vol. 317. - № 7156. - P. 433-437.

[10]	Albini T. A., Sun R. L., Holz E. R. et al. Lemon juice and Candida endophthalmitis in crack-cocaine misuse // Br. J. Ophthalmol. - 2007. - Vol. 91. - № 5. - P. 702-703.

[11]	Derricott J., Preston A., Hunt N. The safer injecting briefing: an easy to use comprehensive reference guide to promoting safer injecting. - Liverpool: HIT, 1999. - 203p.

[12]	Korkia P., Stimson G. Anabolic steroid use in Great Britain: an exploratory investigation. Final report to the Department of Health for England, Scotland and Wales. - London: The Centre for Research on Drugs and Health Behaviour, 1993. - 179 p.

[13]	Lenehan P., Bellis M., McVeigh J. A study of anabolic steroid use in the north west of england // J. Perform. Enhanc. Drugs. - 1996. - Vol. 1. - № 1. - P. 57-70.

[14]	Platt L., Sutton A. J., Vickerman P. et al. Measuring risk of HIV and HCV among injecting drug users in the Russian Federation // Eur. J. Public. Health. - 2009. - Vol. 19. - № 4. - P. 428-433.

[15]	Castro-Sanchez A., Shkedy Z., Hens N. et al. Estimating the force of infection for HCV in injecting drug users using interval-censored data // Epidemiol. Infect. - 2012. - Vol. 140. - № 6. - P. 1064-1074.